semaglutide and alzheimer's Associations of with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US - Wang - 2024 GLP-1 Drug Fails to Improve
Description
Increase gradually to avoid gas and bloating, which are already common during semaglutide dose escalation
This precautionary approach exists because animal studies have shown potential risks to foetal development, although human pregnancy data remains limited
Thereafter, the HR for thyroid cancer in GLP-1RA users declined to 1.27 with two or more years of treatment exposure
Don't hesitate to ask about their experience, monitoring protocols, and post-treatment support
